SCHEMBL1505280

SCHEMBL1505280

COc1ccc([C]=C=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.55
CA2 P00918 3/20 0.55
CA7 P43166 2/20 0.55
CA9 Q16790 2/20 0.55
CA12 O43570 1/20 0.55
CA14 Q9ULX7 1/20 0.55
APP P05067 2/20 0.50
ACHE P22303 1/20 0.46
ALDH1A1 P00352 2/20 0.44
CYP2A6 P11509 1/20 0.44
PKM P14618 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
TDP1 Q9NUW8 3/20 0.44
MAPK1 P28482 2/20 0.44
MGLL Q99685 1/20 0.43
KCNH2 Q12809 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099 0.82 CA1 (0.58) CA1CA2CA7CA9CA12
1,4-Dimethoxybenzene SCHEMBL28441075 0.76 CA1 (0.65) CA1CA2CA7CA9CA12
1,4-Dimethoxybenzene SCHEMBL9648022 0.76 CA1 (0.65) CA1CA2CA7CA9CA12
SCHEMBL10300057 0.76 APP (0.77) CA1CA2CA7CA9CA12
SCHEMBL674764 0.76 APP (0.77) CA1CA2CA7CA9CA12
SCHEMBL4082593 0.76 CA1 (0.65) CA1CA2CA7CA9CA12
1,4-Dimethoxybenzene SCHEMBL21802643 0.74 CA1 (1.00) CA1CA2CA7CA9CA12
1,4-Dimethoxybenzene SCHEMBL8489 0.74 CA1 (1.00) CA1CA2CA7CA9CA12
SCHEMBL9715639 0.74 APP (0.74) CA1CA2CA7CA9CA12
SCHEMBL497836 0.74 CA1 (0.61) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725537-B1 NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-07-13 EP claimed
EP-3112352-B1 OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-11-21 EP disclosed
EP-3112352-A1 OPIOID RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2017-01-04 EP disclosed
EP-2653465-B1 Opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2016-07-13 EP disclosed
EP-2573068-B9 Process for preparing intermediates of compounds useful as opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2015-08-26 EP disclosed
EP-2573068-B1 Process for preparing intermediates of compounds useful as opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2014-12-31 EP disclosed
EP-2653465-A1 Opioid receptor modulators Janssen Pharmaceutica NV (BE) 2013-10-23 EP disclosed
EP-2298744-B1 Opioid receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2013-06-26 EP disclosed
EP-2573068-A1 Process for preparing intermediates of compounds useful as opioid receptor modulators Janssen Pharmaceutica NV (BE) 2013-03-27 EP disclosed
EP-1725537-B1 NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-07-13 EP disclosed
EP-2298744-A2 Opioid receptor modulators Janssen Pharmaceutica NV (BE) 2011-03-23 EP disclosed